Abstract:Importance: While the hallmark pathologies of amyloid-beta and tau in Alzheimer's disease (AD) are well documented and even part of the definition, upstream neuroinflammation is thought to play an important role but remains poorly understood. Objectives: We tested whether two distinct neuroinflammatory markers are associated with cerebrovascular injury and amyloid-beta, and whether these markers are associated with plasma phosphorylated tau (pTau) concentration, medial temporal lobe (MTL) cortical and hippocampal atrophy, and memory deficits. We examined neuroinflammatory markers plasma YKL-40 and GFAP, due to previous conflicting evidence relating YKL-40 and GFAP to AD pathogenic markers. Design: Cross-sectional data from a community observational study (Biomarker Exploration in Aging, Cognition, and Neurodegeneration - BEACoN) were included. Setting: All participants were enrolled in a single site, at University of California, Irvine. Participants: 126 participants were included if they had at least one of the following measures available: neuropsychological data, MRI, amyloid-PET, or plasma. Exposures: Plasma YKL-40 and plasma glial fibrillary acidic protein (GFAP) levels. Main outcomes and measures: White matter hyperintensity (WMH) volume, 18F-florbetapir (FBP) PET mean SUVR, plasma phosphorylated tau (pTau-217) concentration, MTL cortical thickness, hippocampal volume, and memory function assessed by Rey Auditory Verbal Learning Test. Using path analysis, we tested whether higher plasma YKL-40 and GFAP are associated with WMH and amyloid-beta, and whether these converge to downstream markers of tauopathy, MTL neurodegeneration, and memory deficits. Results: In older adults without dementia (N=126, age=70.60+6.29, 62% women), we found that higher plasma YKL-40 concentration was associated with greater WMH volume, while higher plasma GFAP concentration was related to increased FBP SUVR. Further, higher plasma GFAP, WMH and FBP SUVR were independently associated with increased pTau-217. In turn, plasma pTau-217 was associated with reduced MTL cortical thickness and hippocampal volume. Subsequently, only reduced hippocampal volume was related to lower memory function. Conclusions and Relevance: Neuroinflammatory markers contribute to parallel pathways of cerebrovascular injury and amyloid-beta, which converge to tau-associated neurodegeneration and memory deficits in older adults. These observations underscore the need for a more comprehensive approach to developing an AD framework and treatment strategies.

Monomeric C-Reactive Protein Localized in the Cerebral Tissue of Damaged Vascular Brain Regions Is Associated With Neuro-Inflammation and Neurodegeneration-An Immunohistochemical Study

Monomeric C-reactive protein: A novel biomarker predicting neurodegenerative disease and vascular dysfunction

Brain Vascular Expression of Monomeric C-Reactive Protein Is Blocked by C10M Following Intraperitoneal Injection in an ApoE-/- Murine Model of Dyslipidemia: An Immunohistochemical Analysis

Antibody Protection against Long-Term Memory Loss Induced by Monomeric C-Reactive Protein in a Mouse Model of Dementia

C-Reactive Protein, the Gliovascular Unit, and Alzheimer's Disease

Monomeric C‐reactive protein via endothelial CD31 for neurovascular inflammation in an ApoE genotype‐dependent pattern: A risk factor for Alzheimer’s disease?

Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function

The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases

C-reactive Protein Induced Expression of Adhesion Molecules in Cultured Cerebral Microvascular Endothelial Cells.

C-reactive Protein: An Inflammatory Biomarker and a Predictor of Neurodegenerative Disease in Patients With Inflammatory Bowel Disease?

Monomeric C-Reactive Protein Activates Endothelial Cells Via Interaction with Lipid Raft Microdomains

A Meta-Analysis of C-Reactive Protein in Patients with Alzheimer's Disease.

Immunohistochemical Staining Reveals C-reactive Protein Existing Predominantly As Altered Conformation Forms in Inflammatory Lesions.

Parallel neuroinflammatory pathways to cerebrovascular injury and amyloid-beta in Alzheimer's disease

Increased Monomeric Crp Levels in Acute Myocardial Infarction: A Possible New and Specific Biomarker for Diagnosis and Severity Assessment of Disease

Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy

mCRP-Induced Focal Adhesion Kinase-Dependent Monocyte Aggregation and M1 Polarization, Which Was Partially Blocked by the C10M Inhibitor

A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease

Topological Localization of Monomeric C-reactive Protein Determines Proinflammatory Endothelial Cell Responses.

Genetically Proxied CRP (C-Reactive Protein) Levels and Lobar Intracerebral Hemorrhage Risk

Expression of Monocyte Chemoattractant Protein-1 in the Cerebral Artery after Experimental Subarachnoid Hemorrhage